Consolidated Statement of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
NET REVENUES	$ 6,077,667	$ 4,285,514
COST OF REVENUES	7,863,673	4,543,456
GROSS LOSS	(1,786,006)	(257,942)
OPERATING EXPENSES
Research and development	322,269	90,075
Selling, general and administrative expenses	11,350,406	5,747,969
Depreciation and amortization	354,657	218,660
TOTAL OPERATING EXPENSES	12,027,332	6,056,704
OPERATING LOSS	(13,813,338)	(6,314,646)
Interest expense, net	(1,081,226)	(1,326,160)
LOSS FROM CONTINUING OPERATIONS	(14,894,564)	(7,640,806)
DISCONTINUED OPERATIONS
Income from operations of discontinued component	315,119	0
Loss on sale of component	(4,169,718)	0
LOSS ON DISCONTINUED OPERATIONS	(3,854,599)	0
NET LOSS	(18,749,163)	(7,640,806)
Deemed dividend on exchange of warrants	(1,399,661)	0
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(20,148,824)	(7,640,806)
AMOUNTS ATTRIBUTABLE TO COMMON STOCKHOLDERS
Loss from continuing operations	(16,294,225)	(7,640,806)
Loss from discontinued operations	(3,854,599)	0
NET LOSS	$ (20,148,824)	$ (7,640,806)
NET LOSS PER COMMON SHARE, BASIC AND DILUTED
Continuing operations	$ (12.04)	$ (23.61)
Discontinued operations	(2.85)	0.00
NET LOSS PER COMMON SHARE, BASIC AND DILUTED	$ (14.89)	$ (23.61)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	1,352,826	323,633